Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Pinsky

Showing results (111-120 of 162) with videos related to

Pageof 17
Sort By:
Archives of Internal Medicine|November 26, 2008
Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trialYing-Ying Yu, Paul F Pinsky, Neil E Caporaso, et al.
Gynecologic Oncology|September 13, 2016
Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-upPaul F Pinsky, Kelly Yu, Barnett S Kramer, et al.
Digestion|April 4, 2013
Factors associated with the risk of adenoma recurrence in distal and proximal colonAdeyinka O Laiyemo, Chyke Doubeni, Paul F Pinsky, et al.
European Radiology|January 5, 2017
Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participantsDavid S Gierada, Paul F Pinsky, Fenghai Duan, et al.
Plos Medicine|May 26, 2017
Data sharing in clinical trials: An experience with two large cancer screening trialsClaire S Zhu, Paul F Pinsky, James E Moler, et al.
Journal of the National Cancer Institute|July 7, 2005
Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trialJoel L Weissfeld, Robert E Schoen, Paul F Pinsky, et al.
Cancer|December 3, 2016
Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 yearsPaul F Pinsky, Philip C Prorok, Kelly Yu, et al.
JAMA Network Open|March 17, 2023
Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening IntervalsRebecca Landy, Vivian L Wang, David R Baldwin, et al.
JAMA Network Open|February 27, 2023
Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi DeltaRaymond U Osarogiagbon, Wei Liao, Nicholas R Faris, et al.
Urology|August 15, 2006
Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trialPaul F Pinsky, Barnett S Kramer, E David Crawford, et al.
Pageof 17

Showing results (111-120 of 162) with videos related to

Sort By:
Pageof 17
Archives of Internal Medicine|November 26, 2008
Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trialYing-Ying Yu, Paul F Pinsky, Neil E Caporaso, et al.
Gynecologic Oncology|September 13, 2016
Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-upPaul F Pinsky, Kelly Yu, Barnett S Kramer, et al.
Digestion|April 4, 2013
Factors associated with the risk of adenoma recurrence in distal and proximal colonAdeyinka O Laiyemo, Chyke Doubeni, Paul F Pinsky, et al.
European Radiology|January 5, 2017
Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participantsDavid S Gierada, Paul F Pinsky, Fenghai Duan, et al.
Plos Medicine|May 26, 2017
Data sharing in clinical trials: An experience with two large cancer screening trialsClaire S Zhu, Paul F Pinsky, James E Moler, et al.
Journal of the National Cancer Institute|July 7, 2005
Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trialJoel L Weissfeld, Robert E Schoen, Paul F Pinsky, et al.
Cancer|December 3, 2016
Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 yearsPaul F Pinsky, Philip C Prorok, Kelly Yu, et al.
JAMA Network Open|March 17, 2023
Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening IntervalsRebecca Landy, Vivian L Wang, David R Baldwin, et al.
JAMA Network Open|February 27, 2023
Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi DeltaRaymond U Osarogiagbon, Wei Liao, Nicholas R Faris, et al.
Urology|August 15, 2006
Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trialPaul F Pinsky, Barnett S Kramer, E David Crawford, et al.
Pageof 17